News FocusDRUG DEVELOPMENT

Lupus Drug Company Asks FDA for Second Chance

See allHide authors and affiliations

Science  11 Feb 2005:
Vol. 307, Issue 5711, pp. 835
DOI: 10.1126/science.307.5711.835

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Biotech firm pleads for drug's approval so it can afford to prove that it works.